TLE Study
Enrolling Now
Step up against drug-resistant unilateral
temporal lobe epilepsy
A Research Study is Enrolling Now!
Help Advance Unilateral Temporal Lobe Epilepsy Research
A research study is conducted to learn if a new drug, vaccine, booster, treatment, or method is safe and effective. They follow strict scientific standards and regulations to ensure they produce accurate, useful data for health care decision making and to protect the participants.
This research study will test the safety, effectiveness, and tolerability of an investigational gene therapy for adults with temporal lobe epilepsy on only 1 side (unilateral) of the brain that has not responded to current standard-of-care medication.
Taking part in this research study may or may not help your unilateral temporal lobe epilepsy. However, the information collected from you during this study may help doctors learn more about unilateral temporal lobe epilepsy and how to advance treatment options for future generations with the condition.
What can you tell me about this study?
This study is assessing an investigational gene therapy to determine its safety and tolerability in people with uncontrolled unilateral temporal lobe epilepsy. This investigational therapy has been tested in animal models and in samples of the brain collected from people living with unilateral temporal lobe epilepsy. Based on this testing, the US Food and Drug Administration has authorized this first-in-human study.
How does it work?
Answer some questions about your health
Tell us a little bit about yourself
Connect to a study site in your area
It takes just a few minutes to see if you qualify
AcurianHealth helps connect people with research studies that offer treatment under development.
Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.
*In a research study, the participants may receive investigational study medication or an inactive substance (placebo) depending on the study design.
Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.
©2023 Acurian, Inc. All rights reserved.